Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2008 Feb 8.

Published in final edited form as: Mutat Res. 2007 Aug 11;649(1-2):101–113. doi: 10.1016/j.mrgentox.2007.08.004

Table 5.

MN frequency in peripheral blood and bone marrow of male B6C3F1 mice and F344 rats administered acrylamide by oral gavage

Mice
		Microscopy		Flow Cytometry
		BM	PB	PB

Dose (mg/kg)	N¹	MN-RET/1000 RET²

0	5	2.20 ± 0.49	2.00± 0.35	2.76± 0.46
12.5	5	3.20 ± 1.01	3.80± 0.56	3.83± 0.54
25.0	5	4.20 ± 0.70^*	4.10± 0.29^*	4.13± 0.10^*
37.5	5	4.80 ± 0.48^*	4.50± 0.52^*	4.10± 0.23^*
50.0	5	5.00 ± 0.65^*	4.80± 0.51^*	4.35± 0.20^*
Trend test		P = 0.002	P = 0.001	P = 0.005
Rats
		Microscopy		Flow Cytometry
		BM	PB	PB

Dose (mg/kg)	N	MN-RET/1000 RET

0	5	0.60 ± 0.24	0.10 ± 0.10	0.64 ± 0.15
12.5	5	1.30 ± 0.44	0.60 ± 0.24	0.66 ± 0.09
25.0	5	1.10 ± 0.19	0.90 ± 0.19^*	0.66 ± 0.04
37.5	5	1.20 ± 0.30	0.70 ± 0.25	0.51 ± 0.10
50.0	5	0.80 ± 0.30	1.20 ± 0.46^*	0.55 ± 0.03
Trend test		P = 0.382	P = 0.003	P = 0.867

^*

Significantly different from control (P < 0.025/4 = 0.006)

¹

N = number of animals scored

²

Data presented as mean ± SEM; see Methods and Materials, Section 2.4 for analysis procedures used for microscopy-based scoring and FCM-based scoring